Claude Benchimol, SVP, Research & Development at INVITROGEN CORP (IVGN), sold 108,186 shares at $97.50 ($10.5M) on 2007-12-06, disclosed to the SEC on 2007-12-07.
Open-market sale of $10.5M IVGN by SVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.40 | 5,352 | $521K | 4.9% |
| 2 | $97.50 | 1,606 | $157K | 1.5% |
| 3 | $97.50 | 8,032 | $783K | 7.4% |
| 4 | $97.50 | 93,196 | $9.1M | 86.1% |
| Total | $97.50 avg | 108,186 | $10.5M | 100% |